Carrier Free, Recombinant, ExactAb™, Low Endotoxin, Azide Free, Validated, Animal Free, ≥95%(SDS-PAGE&SEC-HPLC), See COA Animal Free,Azide Free,Carrier Free,ExactAb™,Low Endotoxin,Recombinant,Validated for sensitive chromatographic and analytical workflows requiring minimal baseline interference.

🌡

Storage & shipping

Store at -80°C,Avoid repeated freezing and thawing Ships Dry ice packs + Cold packs Check lot-specific COA for exact specifications.

📋

Quality documents

SDS, COA, datasheet, and spec sheet available for download. Lot-specific COA accessible via lot number lookup.

📚

Literature proof

Cited in 0 peer-reviewed publications across chromatography, organic synthesis, and cross-coupling reactions.

Descripción general

Rulonilimab (anti-PDCD1) is a human IgG1 monoclonal antibody against PD-1 that targets, binds and inhibits PD-1 and its downstream signalling pathways with potential immune checkpoint inhibition and anti-tumour activity.

Specifications

Product Name

Rulonilimab (anti-PDCD1) - Anticuerpo primario, specific to PDCD1, Human IgG1

Sinónimos

Especificaciones y pureza

Carrier Free, Recombinant, ExactAb™, Low Endotoxin, Azide Free, Validated, Animal Free, ≥95%(SDS-PAGE&SEC-HPLC), See COA

Mecanismos bioquímicos y fisiológicos

Possible cell death inducer, in association with other factors.

Especies hospedadoras

Humano

Especificidad

PDCD1

Conjugación

Unconjugated

Grado

Animal Free, Azide Free, Carrier Free, ExactAb™, Low Endotoxin, Recombinant, Validated

Isotipo

Human IgG1

Tipo de cadena ligera

kappa

SDS-PAGE

145.78 kDa

Método de purificación

Protein A purified

Concentración

See COA

CAS

2417124-95-7

Almacenamiento y envío

Condiciones de almacenamiento de almacenamiento

Store at -80°C,Avoid repeated freezing and thawing

Enviado en

Dry ice packs + Cold packs

Estabilidad y almacenamiento

Store at -80℃ for 24 months. Upon receipt, it is recommended to aliquot. Avoid freeze/thaw cycle.

Imágenes

Flow Cytometry: Rulonilimab (anti-PDCD1) (Ab191906)

Rulonilimab (anti-PDCD1) (Ab191906) - Flow Cytometry
Flow Cytometry analysis of unstimulated (left) or 500 ng/mL Ionomycin (I139530) and 10 ng/mL PMA (P408905) co-stimulated (right) Jurkat cells labelling PDCD1 (red) with Rulonilimab (anti-PDCD1) (Ab191906) at 0.1 μg/mL for 1 hour at 4°C. Goat Anti-Human IgG (PE) (Ab175838) at a dilution of 1/1000 was used as the secondary antibody. Blue - Isotype control, human IgG (Ab170213). Black - Unlabelled control, cells without incubation with primary antibody.

ELISA: Rulonilimab (anti-PDCD1) (Ab191906)

Rulonilimab (anti-PDCD1) (Ab191906) - ELISA
Immobilized Recombinant Human PD-1 protein (rp176241) at 1.0 μg/mL can bind Rulonilimab (anti-PDCD1) (Ab191906) with the EC50 of 23.57 ng/mL.

SEC: Rulonilimab (anti-PDCD1) (Ab191906)

Rulonilimab (anti-PDCD1) (Ab191906) - SEC
The purity of Rulonilimab (anti-PDCD1) (Ab191906) is more than 95% verified by HPLC.

Documentation

📋 Safety Data Sheet (SDS)

Comprehensive hazard, handling, storage, and regulatory compliance document.

Download SDS →

✅ Certificate of Analysis (COA)

Lot-specific quality data. Enter your lot number to retrieve the exact COA.

Look up COA →

📊 Datasheet

Quick-reference summary of product specifications and applications.

View datasheet →

🔬 Specification Sheet

Full quality attributes and acceptance criteria for this grade.

View spec sheet →

Advanced Data

Objetivos asociados (humanos)

PDCD1 Tclin Programmed cell death protein 1 (0 Activities)

Discover Target: PDCD1

Activity Type	Activity Value -log(M)	Mechanism of Action	Activity Reference	Publications (PubMed IDs)

PDCD1 Tclin Programmed cell death protein 1 (14 Activities)

Discover Target: PDCD1

Activity Type	Relation	Activity value	Units	Action Type	Journal	PubMed Id	doi	Assay Aladdin ID

Mecanismos de acción

Certificados (CoA, COO, BSE/TSE y tabla de análisis)

C of A & Other Certificates(BSE/TSE, COO):

Analytical Chart:

Find and download the COA for your product by matching the lot number on the packaging.

3 results found

Lot Number	Certificate Type	Fecha	Articulo
ZJ24F1113551	Certificate of Analysis	Aug 07, 2026	Ab191906
ZJ24F1113552	Certificate of Analysis	Aug 07, 2026	Ab191906
ZJ24F1113553	Certificate of Analysis	Aug 07, 2026	Ab191906

Calculadoras de soluciones

Molarity Calculator

Determine the necessary mass, volume, or concentration for preparing a solution.

Dilution Calculator

Determine the dilution needed to prepare a stock solution.

Reconstitution Calculator

Reseñas

Need help choosing the grade?

Our grade selection guide covers purity, stabilizer status, and application suitability for all variants in our catalog.

View Animal Free grade guide → View Carrier Free grade guide → View Recombinant grade guide → View Validated grade guide → View ExactAb™ grade guide → View Low Endotoxin grade guide → View Azide Free grade guide →

Bulk & Custom Packaging Need larger quantities or custom specifications? Contact our team for a tailored quote.

Artículos relacionados

Camrelizumab (anti-PD-1) - Anticuerpo primario, for Flow,ELISA,Functional Assay,Kinetics (BLI),Kinetics (SPR) various applications, specific to PDCD1, >95%, Human IgG4SP, ANTAGONIST of Programmed cell death protein 1 antagonist

Cemiplimab (anti-PD-1) - Anticuerpo primario, for ELISA,Functional Assay,Kinetics (BLI),Kinetics (SPR),Flow Cyt various applications, specific to PDCD1, >95%, Human IgG4, Antibody of programmed cell death 1 (CD279)

Nivolumab (anti-PD-1) - Anticuerpo primario, for ELISA,Functional Assay,Flow cytometry,Kinetics (BLI),Kinetics (SPR) various applications, specific to PDCD1/PD-1/CD279, >95%, Human IgG4SP, Antibody of programmed cell death 1 (CD279)

Pembrolizumab (anti-PD-1) - Anticuerpo primario, for ELISA,Functional Assay,Flow cytometry,Kinetics (BLI),Kinetics (SPR) various applications, specific to PDCD1, >95%, Human IgG4SP, Antibody of programmed cell death 1 (CD279)

Mouse Anti-Human IgM Antibody - Anticuerpo secundario, for ELISA various applications, from Human, generated in Mouse, IgG1

Mouse Anti-Human IgG H&L (HRP) - Anticuerpo secundario, for ELISA various applications, from Human, generated in Mouse, IgG1

Goat Anti-Human IgG H&L (HRP) - Anticuerpo secundario, for WB,ELISA,IHC various applications, from Human, generated in Goat, IgG

Mouse Anti-Human IgG Antibody - Anticuerpo secundario, for ELISA,CLIA various applications, from Human, generated in Rat, IgG1

Human IgG - Anticuerpo de control isotípico, for WB,CLIA,LF,EIA,PRTIA various applications, generated in Human, ＞95%, IgG

Spartalizumab (anti-PD-1) - Anticuerpo primario, for ELISA,Functional Assay,Kinetics (BLI),Kinetics (SPR),Flow Cyt various applications, specific to PDCD1, >95%, Human IgG4SP, Antibody of programmed cell death 1 (CD279)

Penpulimab (anti-PDCD1) - Anticuerpo primario, for ELISA,Functional Assay,Flow cytometry,Kinetics (BLI),Kinetics (SPR) various applications, specific to PDCD1, >95%, Human IgG1, Antibody of programmed cell death 1 (CD279)

Sintilimab (anti-PD-1) - Anticuerpo primario, >95%, Human IgG4SP, ANTAGONIST of Programmed cell death protein 1 antagonist

Dostarlimab (anti-PD-1) - Anticuerpo primario, specific to PDCD1, >95%, Human IgG4SP, Antibody of programmed cell death 1 (CD279)

Pidilizumab (anti-PD-1) - Anticuerpo primario, specific to PDCD1, Human IgG1, INHIBITOR of Programmed cell death protein 1 inhibitor

Retifanlimab (anti-PD-1) - Anticuerpo primario, specific to PDCD1, >95%, Human IgG4SP, Antibody of programmed cell death 1 (CD279)

Zimberelimab (anti-PD-1) - Anticuerpo primario, specific to PDCD1, >95%, Human IgG4SP, Antibody of programmed cell death 1 (CD279)

Tislelizumab (anti-PDCD1) - Anticuerpo primario, specific to PDCD1, >95%, Human IgG4SP, INHIBITOR of Programmed cell death protein 1 inhibitor

Goat Anti-Human IgG Antibody - Anticuerpo secundario, ≥ 95%

Mouse Anti-Human IgA H&L Antibody - Anticuerpo secundario, Mouse IgG1

Goat Anti-Human IgG (HRP) - Anticuerpo secundario

Goat Anti-Human IgG (Biotin) - Anticuerpo secundario

PD1 Mouse mAb - Anticuerpo primario, specific to PD1, Mouse IgG1

Goat Anti-Human IgG (Cy5) - Anticuerpo secundario

Goat Anti-Human IgG (APC) - Anticuerpo secundario

Goat Anti-Human IgG (PE) - Anticuerpo secundario

Goat Anti-Human IgG (TRITC) - Anticuerpo secundario

Goat Anti-Human IgG (FITC) - Anticuerpo secundario

Serplulimab (anti-PDCD1) - Anticuerpo primario, specific to PDCD1, >95%, Human IgG4SP, ANTAGONIST of Programmed cell death protein 1 antagonist

Mouse Anti-Human IgE epsilon chain Antibody - Anticuerpo secundario

Cetrelimab (anti-PDCD1) - Anticuerpo primario, specific to PDCD1, >95%, Human IgG4SP, INHIBITOR of Programmed cell death protein 1 inhibitor

Geptanolimab (anti-PDCD1) - Anticuerpo primario, specific to PDCD1, >95%, Human IgG4SP

Goat Anti-Human IgG Fc Antibody - Anticuerpo secundario, Goat IgG

Budigalimab (anti-PD-1) - Anticuerpo primario, specific to PDCD1, Human IgG1, INHIBITOR of Programmed cell death protein 1 inhibitor

Sasanlimab (anti-PD-1) - Anticuerpo primario, specific to PDCD1, Human IgG4SP, ANTAGONIST of Programmed cell death protein 1 antagonist

Balstilimab (anti-PD-1) - Anticuerpo primario, specific to PDCD1, Human IgG4SP-Opti, ANTAGONIST of Programmed cell death protein 1 antagonist

Pimivalimab (anti-PD-1) - Anticuerpo primario, specific to PDCD1, >95% (SDS-PAGE&SEC), Human IgG4SP, INHIBITOR of Programmed cell death protein 1 inhibitor

Ezabenlimab (anti-PD-1) - Anticuerpo primario, specific to PDCD1, >95% (SDS-PAGE&SEC), Human IgG4SP

Toripalimab (anti-PD-1) - Anticuerpo primario, specific to PDCD1, Human IgG1, ANTAGONIST of Programmed cell death protein 1 antagonist

Human IgG2-Kappa - Anticuerpo de control isotípico, Human IgG2

Human IgG3-kappa - Anticuerpo de control isotípico, Human IgG3

Finotonlimab (anti-PD-1) - Anticuerpo primario, specific to PDCD1, Human IgG4SP, INHIBITOR of Programmed cell death protein 1 inhibitor

PD1 Mouse mAb (FITC) - Anticuerpo primario, specific to PD1, Mouse IgG1

PD1 Mouse mAb (PE) - Anticuerpo primario, specific to PD1, Mouse IgG1

PD1 Mouse mAb (APC) - Anticuerpo primario, specific to PD1, Mouse IgG1

PD1 Mouse mAb (Biotin) - Anticuerpo primario, specific to PD1, Mouse IgG1

Peresolimab (anti-PD-1) - Anticuerpo primario, specific to PDCD1, Human IgG1

Rosnilimab (anti-PD-1) - Anticuerpo primario, specific to PDCD1, Human IgG1

PD1/CD279 Mouse mAb - Anticuerpo primario, specific to PD1/CD279, Mouse IgG1

Human IgG1-kappa, anti-Spike RBD - Anticuerpo de control isotípico, specific to Spike RBD, Human IgG1

Human IgG4-kappa - Anticuerpo de control isotípico, IgG4

Goat Anti-Human IgG (AF647) - Anticuerpo secundario, IgG

Goat Anti-Human IgG (AF405) - Anticuerpo secundario, IgG

Human IgG (FITC) - Anticuerpo de control isotípico, IgG

Human IgG (APC) - Anticuerpo de control isotípico, IgG

Human IgG (PE) - Anticuerpo de control isotípico, IgG

Human IgG1(P331S/E430G)-kappa, anti-HEL - Anticuerpo de control isotípico, specific to HEL, Human IgG1(P331S/E430G)

Human IgG1(D265A/N297A)-kappa, anti-HEL - Anticuerpo de control isotípico, specific to HEL, Human IgG1(D265A/N297A)

Human IgG1(K409R/E356D/M358L)-kappa, anti-HEL - Anticuerpo de control isotípico, specific to HEL, Human IgG1(K409R/E356D/M358L)

Human IgG1(P329G/E356D/M358L)-kappa, anti-HEL - Anticuerpo de control isotípico, specific to HEL, Human IgG1(P329G/E356D/M358L)

Human IgG1(F405L)-kappa, anti-HEL - Anticuerpo de control isotípico, specific to HEL, Human IgG1(F405L)

Human IgG1(N297Q)-kappa, anti-HEL - Anticuerpo de control isotípico, specific to HEL, Human IgG1(N297Q)

Human IgG (Biotin) - Anticuerpo de control isotípico, IgG

Human IgG1(N297S)-kappa, anti-HEL - Anticuerpo de control isotípico, specific to HEL, Human IgG1(N297S)

Human IgG1(E233A/L235A)-kappa, anti-HEL - Anticuerpo de control isotípico, specific to HEL, Human IgG1(E233A/L235A)

Human IgG1(K214R/N297A)-kappa, anti-HEL - Anticuerpo de control isotípico, specific to HEL, Human IgG1(K214R/N297A)

Human IgG1(K214R/L234A/L235A)-kappa, anti-HEL - Anticuerpo de control isotípico, specific to HEL, Human IgG1(K214R/L234A/L235A)

Human IgG1(N297A/E356D/M358L)-kappa, anti-HEL - Anticuerpo de control isotípico, specific to HEL, Human IgG1(N297A/E356D/M358L)

Human IgG1(L234F/L235E)-kappa, anti-HEL - Anticuerpo de control isotípico, specific to HEL, Human IgG1(L234F/L235E)

Human IgG1(D265A)-kappa, anti-HEL - Anticuerpo de control isotípico, specific to HEL, Human IgG1(D265A)

Human IgG1(K214R/L234F/L235E/P331S)-kappa, anti-HEL - Anticuerpo de control isotípico, specific to HEL, Human IgG1(K214R/L234F/L235E/P331S)

Human IgG1(K214R/E356D/M358L)-kappa, anti-HEL - Anticuerpo de control isotípico, specific to HEL, Human IgG1(K214R/E356D/M358L)

Human IgG1(L234A/L235A/G237A)-kappa, anti-HEL - Anticuerpo de control isotípico, specific to HEL, Human IgG1(L234A/L235A/G237A)

Human IgG1(L234A/L235A/F405L)-kappa, anti-HEL - Anticuerpo de control isotípico, specific to HEL, Human IgG1(L234A/L235A/F405L)

Human IgG1(D270N)-kappa, anti-HEL - Anticuerpo de control isotípico, specific to HEL, Human IgG1(D270N)

Human IgG4(S228P)-kappa, anti-HEL - Anticuerpo de control isotípico, specific to HEL, Human IgG4(S228P)

Human IgG1(N297A)-kappa, anti-HEL - Anticuerpo de control isotípico, specific to HEL, Human IgG1(N297A)

Human IgG4(S228P/L235E/P329G)-kappa, anti-HEL - Anticuerpo de control isotípico, specific to HEL, Human IgG4(S228P/L235E/P329G)

Human IgG1-lambda1, anti-Spike RBD - Anticuerpo de control isotípico, specific to Spike RBD, Human IgG1

Human IgG1-lambda2, anti-Spike RBD - Anticuerpo de control isotípico, specific to Spike RBD, Human IgG1

Iparomlimab (anti-PDCD1) - Anticuerpo primario, specific to PDCD1, Human IgG4SP

Prolgolimab (anti-PDCD1) - Anticuerpo primario, specific to PDCD1, Human IgG1

Nofazinlimab (anti-PDCD1) - Anticuerpo primario, specific to PDCD1, Human IgG4SP

Goat Anti-Human IgG (AF555) - Anticuerpo secundario, IgG

Human IgG1-kappa (AF405), anti-Spike RBD - Anticuerpo de control isotípico, specific to Spike RBD

Human IgG1-kappa (AF647), anti-Spike RBD - Anticuerpo de control isotípico, specific to Spike RBD

Human IgG1-kappa (APC), anti-Spike RBD - Anticuerpo de control isotípico, specific to Spike RBD

Human IgG1-kappa (Biotin), anti-Spike RBD - Anticuerpo de control isotípico, specific to Spike RBD

Human IgG1-kappa (AF700), anti-Spike RBD - Anticuerpo de control isotípico, specific to Spike RBD

Human IgG1-kappa (FITC), anti-Spike RBD - Anticuerpo de control isotípico, specific to Spike RBD

Human IgG1-kappa (AF555), anti-Spike RBD - Anticuerpo de control isotípico, specific to Spike RBD

Centrose patent anti-dysadherin (anti-Dysadherin) - Anticuerpo primario, specific to FXYD5

Human IgG (AF647) - Anticuerpo de control isotípico

Human IgG (AF488) - Anticuerpo de control isotípico

Human IgG (AF700) - Anticuerpo de control isotípico

Human IgG (AF405) - Anticuerpo de control isotípico

Goat Anti-Human IgG (AF488) - Anticuerpo secundario

Goat Anti-Human IgG Fc (Cy5) - Anticuerpo secundario

Goat Anti-Human IgG Fc (AF555) - Anticuerpo secundario, specific to Human IgG Fc

Goat Anti-Human IgG Fc (TRITC) - Anticuerpo secundario

Goat Anti-Human IgG Fc (AF700) - Anticuerpo secundario, specific to Human IgG Fc

Goat Anti-Human IgG Fc (AF405) - Anticuerpo secundario

Goat Anti-Human IgG Fc (Biotin) - Anticuerpo secundario, specific to Human IgG Fc

Goat Anti-Human IgG Fc (AF647) - Anticuerpo secundario

Goat Anti-Human IgG Fc (FITC) - Anticuerpo secundario, specific to Human IgG Fc

Human IgG (AF555) - Anticuerpo de control isotípico